Navidea Biopharmaceuticals Announces Patent Extension for Lymphoseek® Business Wire
DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the …
Navidea Biopharmaceuticals Announces Patent Extension for Lymphoseek® Business Wire
DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the …